According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
A recent study found that tirzepatide, the active ingredient in Zepbound and Mounjaro, could reduce the risk of ...
In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...
Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...
A new study suggests semaglutide drugs like Ozempic, used for type 2 diabetes, may lower the risk of opioid overdose in ...
Employers that cover GLP-1s are partnering with vendors to design benefits and manage lifestyle programs, but the "jury is ...
Biocon Limited, an innovation-led global biopharmaceutical company, today announced the signing of a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company.
Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...
With a nod to the relatively new drugs in diabetes care, Khunti also noted the role of registries in generating real-world ...